Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
A Synthetic Cross-Species CD200R1 Agonist Suppresses Inflammatory Immune Responses In Vivo. [electronic resource] by
- Prodeus, Aaron
- Sparkes, Amanda
- Fischer, Nicholas W
- Cydzik, Marzena
- Huang, Eric
- Khatri, Ismat
- Young, Ashley
- Woo, Lindsay
- Chow, Chung Wai
- Gorczynski, Reginald
- Gariépy, Jean
Publication details: Molecular therapy. Nucleic acids Sep 2018
In:
Molecular therapy. Nucleic acids vol. 12
Availability: No items available.
|
|
12.
|
Slow binding kinetics of secreted protein, acidic, rich in cysteine-VEGF interaction limit VEGF activation of VEGF receptor 2 and attenuate angiogenesis. [electronic resource] by
- Cydzik, Marzena
- Abdul-Wahid, Aws
- Park, Soyeon
- Bourdeau, Annie
- Bowden, Katherine
- Prodeus, Aaron
- Kollara, Alexandra
- Brown, Theodore J
- Ringuette, Maurice J
- Gariépy, Jean
Producer: 20151019
In:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology vol. 29
Availability: No items available.
|
|
13.
|
Serum-derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re-modeling of the extracellular matrix that favors the engraftment of CEA-expressing tumor cells. [electronic resource] by
- Abdul-Wahid, Aws
- Cydzik, Marzena
- Fischer, Nicholas W
- Prodeus, Aaron
- Shively, John E
- Martel, Anne
- Alminawi, Samira
- Ghorab, Zeina
- Berinstein, Neil L
- Gariépy, Jean
Producer: 20190125
In:
International journal of cancer vol. 143
Availability: No items available.
|
|
14.
|
Induction of antigen-specific TH 9 immunity accompanied by mast cell activation blocks tumor cell engraftment. [electronic resource] by
- Abdul-Wahid, Aws
- Cydzik, Marzena
- Prodeus, Aaron
- Alwash, Mays
- Stanojcic, Mile
- Thompson, Megan
- Huang, Eric H-B
- Shively, John E
- Gray-Owen, Scott D
- Gariépy, Jean
Producer: 20170428
In:
International journal of cancer vol. 139
Availability: No items available.
|
|
15.
|
VISTA.COMP - an engineered checkpoint receptor agonist that potently suppresses T cell-mediated immune responses. [electronic resource] by
- Prodeus, Aaron
- Abdul-Wahid, Aws
- Sparkes, Amanda
- Fischer, Nicholas W
- Cydzik, Marzena
- Chiang, Nicholas
- Alwash, Mays
- Ferzoco, Alessandra
- Vacaresse, Nathalie
- Julius, Michael
- Gorczysnki, Reginald M
- Gariépy, Jean
Producer: 20190826
In:
JCI insight vol. 2
Availability: No items available.
|